An interventional study of The COPUS intervention and Usual Care (OPUS treatment) in Schizophrenia, Schizotypal Disorder and First Episode Psychosis, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2018-09-14.
Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Supportive care
Among 79 studies in Schizophrenia with a site in Denmark — 10 open to participants now, 12 under way, none of them phase 3. Schizophrenia · Denmark.
Among the 79 studies in Schizophrenia with a site in Denmark, this one is the 61st largest by enrollment of the 67 interventional ones that give a count, is one of 2 that started in 2018, is one of 38 with no phase, and was the 52nd registered.
3,563 studies on the registry are indexed under Schizophrenia; 491 are open to participants now.
Browse Schizophrenia studies →10 of the 79 studies in Schizophrenia with a site in Denmark are open now. Recruiting first, the newest first:
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Sites in Denmark
Nikolai Albert · Sites in Denmark
Anders Fink-Jensen, MD, DMSci · Sites in Denmark
Ole Köhler-Forsberg · Sites in Denmark
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Sites in Denmark
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 331 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 257 (78%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.
This study: 18 Years to 35 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
79 studies; the count open now beside each. This study's row is marked.
First in 1997; this study’s year is marked. 2 started in 2018.
This study's enrollment of 27 is below the median of 71 across 2,944 interventional studies indexed under Schizophrenia.
Median enrollment 108 across the 67 interventional studies, 203 across the 11 observational. Of the 61 that completed or were terminated, 5 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 79 have an industry lead sponsor. The 10 most frequent:
Rigshospitalet, Denmark is the lead sponsor of 1,007 studies on the registry; 175 are open to participants now.
Rigshospitalet, Denmark has 1 study filed under Schizophrenia — fewer than ten, so there is no comparison to draw.
4 of the studies in Schizophrenia with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07716969Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalTOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis | 2026-12-31 |
| NCT06431009University of AarhusThe Danish Region Midt Schizophrenia Cohort | 2026-12-31 |
| NCT07082777University of AarhusRecovery in Telling Life Stories | 2027-04-01 |
| NCT07404085Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalEpigenetic Enhancement of Cognitive Training in Aging Mood and Schizophrenia Spectrum Disorder Populations | 2027-07-01 |
Among the 79 studies in Schizophrenia with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of the COPUS study is to investigate, whether it is possible to recruit and retain young people with first-episode psychosis, to an 8 week supervised High-Intensity Functional Training intervention (HIFT) (i.e. COPUS Intervention) and to investigate if oxygen uptake, body composition and physical function improves following participation in the intervention.
The introduction of specialized early intervention (SEI) is stated to be the most successful recent addition to the treatment of schizophrenia and other psychotic illnesses. In Denmark, SEI teams called OPUS, offer early intervention treatment (i.e. OPUS treatment) to young patients between 18 and 35 years with first-episode psychosis. The OPUS treatment consists of three main pillars: modified assertive treatment, family involvement, and social skill training. OPUS treatment is delivered via multidisciplinary teams including psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists.
Despite considerable progress in treatment of schizophrenia, people diagnosed with schizophrenia live significantly shorter lives, compared to the rest of the population. The higher mortality rate can be partly explained by an increased risk of cardiovascular disease, including metabolic syndrome, which may be documented already in the first months after start of medical anti-psychotic treatment. It is widely acknowledged that physical activity constitutes a cornerstone in the prevention of cardiovascular disease and metabolic syndrome. Therefore, despite the influence of non-modifiable factors (e.g. genetics), it is reasonable to assume that physical activity can promote health and prevent somatic disease in people diagnosed with schizophrenia.
However, currently, physical activity is not included in early intervention treatment of schizophrenia. Moreover, people with schizophrenia may experience anxiety, loss of motivation, apathy and social isolation, which can constitute significant barriers for adherence to physical activity. Existing knowledge in relation to physical activity behaviour change and adoption is therefore difficult to transfer directly to people with schizophrenia. Development and testing of new initiatives, which can be integrated into clinical practice, and offered complementary to SEI are thus warranted.
Against this background, the aim of the current study (called the COPUS study) is to investigate, whether it is possible to recruit and retain young people with first-episode psychosis, to an 8-weeks supervised High-Intensity Functional Training (HIFT) intervention (i.e. COPUS intervention) and to investigate if oxygen uptake, body composition and physical function changes following participation in the COPUS intervention. The study is organized as a randomized mixed methods feasibility study.
The COPUS intervention is offered in a private fitness centre in the local community. The intervention contains three training sessions of one hour duration per week, with the recommendation to the participants, to take part in at least two sessions per week.
The investigators aim to include 30 participants whom will be randomly assigned (1:1) to either an intervention group receiving the COPUS intervention plus usual care (i.e. standard OPUS treatment) or a control group including only receiving usual care (i.e. standard OPUS treatment). Participants allocated to the control group are offered the COPUS intervention after eight weeks.
The design and choice of methods reflect the complexity of the intervention (combination of social and physical elements that are difficult to control and isolate) and the desire to establish a scientifically informed basis for a subsequent, up-scaled, pragmatic randomized multicentre study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The COPUS intervention plus usual care (OPUS treatment).
Other: The COPUS intervention · Other: Usual Care (OPUS treatment)
Usual care (OPUS treatment).
Other: Usual Care (OPUS treatment)
The COPUS intervention consists of 8 weeks of High-Intensity Functional Training (HIFT). The frequency of the training is 3 sessions per week and the duration is one hour per session. The intervention is group-based and supervised. Each training session includes warm-up (15 min), followed by 30 minutes of HIFT based on a range of varied functional exercises, including elements of strength training and aerobic exercise. The sessions are supervised by a trained physiotherapist and exercise physiologist supported by 2 two trained bachelor students in Sports Science.
Usual care include specialised early intervention treatment (OPUS treatment) and consists of three main pillars: modified assertive treatment, family involvement, and social skill training. OPUS treatment is delivered via multidisciplinary teams include psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists. All team members, except for the psychiatrist, function as case managers. The ratio of patients to case managers must not exceed 12:1.
Assessment of changes in Physical Fitness (VO2max)
Assessed by the maximum amount of oxygen the body can utilize during a specified period of intense exercise.
Time frame: Change from Baseline Physical Fitness (VO2max) at 2 months.
Recruitment Rate
Registration of patients enrolled in the study compared to the total number of eligible patients.
Time frame: Registration of recruitment occurs in the 4 weeks prior to the baseline tests.
Retention Rate
Registration of the participants attendance in the High-Intensity Functional Training compared with the number of possible training sessions during the period.
Time frame: From baseline up to 4 months.
Assessment of changes in body weight
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining body weight.
Time frame: Change from Baseline Body Weight at 2 months.
Assessment of changes in fat percentage
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining fat percentage.
Time frame: Change from Baseline Fat Percentage at 2 months.
Assessment of changes in bone mass
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining bone mass.
Time frame: Change from Baseline Bone Mass at 2 months.
Assessment of changes in muscle mass
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining muscle mass.
Time frame: Change from Baseline Muscle Mass at 2 months.
Assessment of changes in Visceral Fat
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining visceral fat.
Time frame: Change from Baseline Visceral Fat at 2 months.
Assessment of changes in Resting Blood Pressure
The participants' Resting Blood Pressure are tested according to the American Heart Association practice guidelines for blood pressure Measurement.
Time frame: Change form Baseline Resting Blood Pressure at 2 months.
Assessment of changes in countermovement jump height
Determination of potential changes in countermovement jump height measured using the non-invasive Optojump system (www.optojump.com)
Time frame: Change form Baseline Jump Height at 2 months.
Assessment of changes in Leg Muscle Strength
Determination of potential changes in leg muscle strength by the non-invasive 30-Second Chair Stand test. The test measures how many times the participant can reach a full standing position from a sitting position in 30 seconds. Score range from 0 and up with a higher score being considered as a better outcome.
Time frame: Change form Baseline Leg Muscle Strength at 2 months.
Assessment of changes in Hand Grip Strength
Determination of potential changes in grip strength measured quantitatively using a hand dynamometer.
Time frame: Change form Baseline Hand Grip Strength at 2 months.
Assessment of changes in Balance
Determination of potential changes in balance using the Flamingo Balance Test. The participant stands on a 3 centimeter wide beam while holding the instructors hand. The tests then measures how many times the participant loses balance in 60 seconds.Score range from 0 and up with a lower score being considered as a better outcome.
Time frame: Change form Baseline balance at 2 months.
Assessment of changes in Self-reported Physical Activity Behavior
Assesment of changes in self-reported physical activity behaviour using the Physical Activity Scale (PAS). The PAS measures self-reported amount of time spent on different physical activities, such as sports, work, and leisure time during 24 hours on an average weekday. The activities are organized in nine different metabolic equivalent (MET) levels ranging from sleep/rest (0.9 METs) to high-intensity physical activities (\>6 METs). MET is the Metabolic Equivalent of Task and is a physiological measure expressing the energy cost of physical activities and is defined as the ratio of metabolic rate (and therefore the rate of energy consumption) during a specific physical activity to a reference metabolic rate. Therefore, higher MET scores in the Physical Activity Scale indicates a better outcome than lower scores.
Time frame: Change from Baseline Physical Activity Behaviour at 2 months.
Monitoring of training intensity (for the Intervention Group only)
Determination of whether the training intensity is adequate to increase Physical Fitness, the workload during training is continuously measured. A validated device called Actiheart which is both an accelerometer and a heart rate monitor is used to measure workload.
Time frame: Through study completion, an average of 4 months
Adverse events
We will continuously record adverse events that may arise as a result of the intervention, including physical damage, discomfort and any deterioration of symptoms. The adverse events will be registred both in the intervention period and in the Control Group training period.
Time frame: Through study completion, an average of 4 months
Resource Consumption
In order to evaluate the sustainability of the intervention, we want to register how much time (in minutes) OPUS staff spends on the project
Time frame: Through study completion, an average of 4 months
Ran from Jan 2018 to primary completion in Jun 2018, 4 months.
Of 753 non-industry interventional studies with no phase under Schizophrenia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's 4 months is below that.
Counting every sponsor, half of 766 studies reached it within 32 months; a quarter within 16 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.